skip to content

Summit Therapeutics

16:50 on 20/11/2017

Current Price 170.22p | Bid 167.00p | Ask 175.00p | Change 2.09%

Company Overview

Summit Therapeutics plc (formerly Summit Corporation plc, formerly VASTox plc) is an international biopharmaceutical company focussed on the discovery and development of novel medicines to treat the fatal muscle wasting disease Duchenne Muscular Dystrophy and infections caused by the bacteria C. difficile. Summit's goal is to become a fully integrated biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies.

Stock Details

Shares in Issue 61,290,740
Market cap £ 60.98m
Sector Pharmaceuticals & Biotechnology
Indices FTSE AIM All-Share Index

Financial Highlights Year Ended 31/01/2014

Turnover £1.38 million
Operating Profit £-6.71 million
Dividend Yield 0.00
Dividend Per Share 0.00
Dividend Cover 0.00
P/E Ratio -2.43
» More Financials

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Price Summary

Mid Price ? 171.00p
Bid Price ? 167.00p
Ask Price ? 175.00p
Volume ? 4120
Change Today 3.50p
% Change Today 2.09%
Open 168.00p
Previous Close 171.00p
Intraday High 170.32p
Intraday Low 168.00p
52 Week High 157.50p
52 Week Low 82.50p

Intra-Day Chart

More Charts »

Broker Consensus

The above information represents a selection of the views and target prices published in the last 120 days by analysts in individual stocks. It is subject to change without notice and may not necessarily be the view held by Redmayne-Bentley.

Client Area Access

» Secure Login

» Not registered yet?

Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.